Sponsored Content | Webinar | Advanced Visualization| August 29, 2017

WEBINAR: Multi-Modality 3-D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives

This webinar is supported by an educational grant from Philips Healthcare

Liver cancer advanced imaging. Webinar will cover new advances for more precise targeting of Liver Cancer.

The webinar "Multi-Modality 3D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives" focuses on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies. It introduces the audience to the mechanisms and principles of image analysis, outlines the growing role of machine learning for the therapeutic algorithm and the decision making processes in interventional oncology.

The webinar took place Oct. 3, 2017. Watch the recorded archive version of this webinar by registering.

Register to watch the archive version of this webinar

 

Statement of Purpose
Liver cancer is the second most common cause of cancer-related death worldwide and most cases are diagnosed at intermediate to advanced stages of the disease, making most patients no longer amenable to surgical therapies. Minimally invasive, loco-regional image guided therapies, such as chemoembolization, have become the mainstay therapy for such patients. These image-guided interventions also gave birth to the new field of interventional oncology, a subspecialty of interventional radiology which is increasingly considered as the new and fourth pillar of cancer care (next to medical, surgical and radiation oncology). The explosive growth of such therapies requires new and more efficient intra- and post-procedural imaging solutions. This webinar will focus on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies and introduce the audience to the mechanisms of action, principles of image analysis and the growing role of machine learning for the therapeutic algorithm and decision making in interventional oncology.

 

Learning Objectives
Upon completion of this activity, particpants will be able to:

• Summarize the principles and applications of image-guided minimally invasive tumor therapy.
• Describe the role of cancer imaging and multi-modality tumor tracking for local therapies of liver cancer.
• Review novel software-assisted 3-D quantitative tools to evaluate surrogate endpoints of therapeutic efficacy.
• Explain the growing role of machine learning in the automation and standardization of image analysis.

 

Intended Audience:
This activity is intended for oncologists, radiologist, nurse practitioners, biomedical engineers, and other clinicians interested in the management of liver cancer.

 

Presenter

Julius Chapiro, M.D., Ph.D.Julius Chapiro, M.D., Ph.D.
Research Scientist and Resident Physician
Yale School of Medicine

Dr. Chapiro is a research scientist at the Department of Radiology and Biomedical Imaging, Yale University School of Medicine. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen, he served as a postdoctoral fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin.

Dr. Chapiro works on the development of novel imaging biomarkers, tumor response criteria, staging systems and molecular imaging techniques for image-guided liver cancer therapies. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on tumor metabolism and immuno-oncology. With over 50 peer-reviewed publications, book chapters and news articles, Dr. Chapiro advocates the element of personalized medicine in interventional oncology, which is the most rapidly growing field in interventional radiology practice. Creating innovative and clinically practicable solutions and translating them from concept to practice has been his central mission for the past five years.  He is the co-director of the Yale Radiology Research laboratory.

 

Register to watch the archive version of this webinar

Related Content

News | Cardiac Imaging

June 24, 2022 — The Radiological Society of North America (RSNA) reports that Coronary Artery Calcium (CAC) scoring with ...

Time June 24, 2022
arrow
News | Lung Imaging

June 24, 2022 — Xoran Technologies announced they have begun work on Phase 2 of their mobile lung grant with the goal to ...

Time June 24, 2022
arrow
News | Artificial Intelligence

June 22, 2022 — Gradient Health, a medical technology company based in North Carolina, announced a new initiative which ...

Time June 22, 2022
arrow
News | Computed Tomography (CT)

June 16, 2022 — Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly ...

Time June 16, 2022
arrow
News | Artificial Intelligence

June 14, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), incorporating AI support into clinical ...

Time June 14, 2022
arrow
News | PET-CT

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...

Time June 14, 2022
arrow
News | SPECT-CT

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro ...

Time June 13, 2022
arrow
Feature | Digital Radiography (DR) | By ResearchAndMarkets

The "Mobile Imaging Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's ...

Time June 09, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
News | Contrast Media

June 1, 2022 — The current shortage of iodinated contrast in the United States due to the COVID-19 related production ...

Time June 01, 2022
arrow
Subscribe Now